Navigation Links
Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma
Date:11/25/2008

is no evidence that Litx produces the typical side effects from the systemic damage to rapidly-dividing normal cells caused by chemotherapy, radiation, and other cancer treatments. As a single-use disposable drug and device combination, Litx is being developed solely as a drug product through the oversight of FDA's Center for Drug Evaluation and Research (CDER).

About Light Sciences Oncology

Light Sciences Oncology (LSO) is the developer of an innovative light-activated drug treatment for solid tumors known as Light Infusion Therapy(TM) (Litx(TM)). The drug treatment is activated by a palm-sized, single-use, disposable unit that provides easy use for physicians and tolerable, effective, and repeatable treatments for cancer patients. In addition to the Phase 3 HCC trial, LSO is also treating patients in a Phase 3 trial for metastatic colorectal cancer. Based on the mechanism of action of Litx treatment, additional applications of Litx may also include benign neoplasms--growths of non-cancerous tissue that nonetheless have implications for patient morbidity and even mortality. LSO has completed a Phase 1/2 trial and has initiated a Phase 2a trial in benign prostatic hyperplasia (BPH), or enlargement of the prostate. The company has positioned itself for growth with a strong portfolio of intellectual property, innovation applications in development, and an exceptionally capable and efficient team.

    Contacts

    Robert M. Littauer
    Vice President, Chief Financial Officer and Treasurer
    425-957-8900
    bobl@lsoncology.com

    Llew Keltner, M.D., Ph.D.
    President and CEO
    425-957-8900
    dr_llew@lsoncology.com

Website: www.lsoncology.com

Light Infusion Therapy(TM), Litx(TM), and LS11(R) are trademarks of Light Sciences Onco
'/>"/>

SOURCE Light Sciences Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
2. Opportunities to Highlight Type 1 Diabetes in November
3. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
4. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
5. New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
6. Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
7. Theranostics Health Receives Green Light to Perform Clinical Testing
8. September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
9. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
10. August 2008 Mayo Clinic Womens HealthSource Highlights Avoiding Blood Pressure Increase at Menopause, Healthful Benefits of Dark Chocolate and Scheduling a Colorectal Exam
11. New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SHENZHEN , Chine, 3 juillet 2015 ... séquençage à haut débit de l,ADN situé à ... la certification de  l,American College of Pathologists  (Collège ... BGI à Hong Kong ... nouvelle génération à recevoir la certification du CAP ...
(Date:7/2/2015)... HILL, N.C. , July 2, 2015  New ... Because of its leading role in educating thought leaders ... functions that can heavily influence how well a new ... a new study from research and consulting leader Best ... Affairs leaders need to focus on are early stage ...
(Date:7/2/2015)... NEW YORK , July 2, 2015 /PRNewswire/ ... of a conspicuously high-growth market segment in hematology ... research publisher said that Roche,s recent unveiling of its ... into the cobas m 511 hematology ... not only capture growth enjoyed by current leader ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... Dec. 27, 2010 King Pharmaceuticals®, Inc. (NYSE: ... PTIE ) today announced that King has resubmitted a ... Food and Drug Administration (FDA) in response to a Complete ... is a Class 2 resubmission with a six month review ...
... Cepheid (Nasdaq: CPHD ) today announced ... investor conference, and invited investors to participate via webcast.J. ... a.m. Pacific TimeTo access the live webcast for this ... at least 15 minutes before the scheduled start time ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3Cepheid to Webcast Upcoming Financial Presentation 2
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... ... 03, 2015 , ... Scientists at several top US cancer centers believe they ... exposure. Click here to read the complete story , just posted on the ... Sinai Medical Center, and New York University exposed mice with a mutation on the ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the ... good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce a ... added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the 19th sweetFrog store located in the Lone Star State. The premium frozen yogurt ... in 2014. , The store, which opened July 1 at Duke’s Travel Plaza, is ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... fatigue is often a major problem for cancer ... completing therapy. Researchers at Mayo Clinic ( http://www.mayoclinic.org/oncology-rst/ ... ( http://ncctg.mayo.edu/ ) (NCCTG) recently completed a study ... and found that, while it did not improve ...
... M.D., Ph.D., FASTRO, and William McBride, D.Sc., Ph.D., have ... Oncology,s most prestigious award, the Gold Medal. They will ... during ASTRO,s 52nd Annual Meeting, taking place October 31 ... Medal is bestowed on revered members who have made ...
... ... targeted internet traffic to their websites. The solution is all in the PT Marketing Academy. ... to use WordPress blogs, search engine optimization for Google search, Facebook, Twitter, YouTube, and all ... ...
... Montreal, Quebec June 2, 2010 Baby boomers retiring ... in Canada or the U.S., however, a study suggests retirees ... and from the mainstream of Mexican life. The study, ... presented at the 2010 Congress for the Humanities and Social ...
... current problem is the mission of analytical chemistry, according to ... the University of the Basque Country (UPV/EHU). The group,s name ... these problems - Farmartem: the abbreviation in Spanish of pharmaceuticals, ... Art has been the line of research least worked on ...
... after mastectomy fared better, researchers say , WEDNESDAY, June ... after a mastectomy may influence the odds of breast ... the Catholic University of Louvain (Leuven) in Belgium looked ... in 327 women from one to four years after ...
Cached Medicine News:Health News:Results from a study testing methylphenidate for cancer-related fatigue 2Health News:Results from a study testing methylphenidate for cancer-related fatigue 3Health News:Larson, McBride named 2010 ASTRO Gold Medalists 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 3Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 4Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 5Health News:Retirees in Mexico cut off, study says 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 3
151 channels cover the entire head with a high density, with provisions for the eyes and ears. Patients and subjects are examined in a comfortable seated position or laying down....
... is achieved using an increased tilt angle ... patient bed. The patient preparation can be ... case of an emergency the patient can ... for e.g. resuscitation purposes. The integrated neck ...
... be used for demonstration and training in: ... , ,The Model Practice Eye is ... the human eye size and shape and the ... lens and pupil arrangement simulate the optics of ...
... Canons DR innovations, the CXDI-31 is the ... compact and lightweight design, the Canon CXDI-31 ... screen-film cassettes. It is designed to capture ... get with fixed devices and supports lateral ...
Medicine Products: